Roivant Sciences Ltd to Provide Update Regarding Initiation of Patent Litigation Against Moderna - Conference Call Transcript - Thomson StreetEvents

Roivant Sciences Ltd to Provide Update Regarding Initiation of Patent Litigation Against Moderna - Conference Call Transcript

Roivant Sciences Ltd to Provide Update Regarding Initiation of Patent Litigation Against Moderna - Conference Call Transcript - Thomson StreetEvents
Roivant Sciences Ltd to Provide Update Regarding Initiation of Patent Litigation Against Moderna - Conference Call Transcript
Published Feb 28, 2022
Published Feb 28, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of ROIV.OQ conference call or presentation 28-Feb-22 1:00pm GMT

  
Report Type:

Transcript

Source:
Company:
Roivant Sciences Ltd
Ticker
ROIV.OQ
Time
1:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Roivant Sciences Ltd Q1 2022 Earnings Call Transcript – 2022-08-15 – US$ 54.00 – Edited Transcript of ROIV.OQ earnings conference call or presentation 15-Aug-22 12:00pm GMT

Roivant Sciences Ltd Q4 2021 Earnings Call Transcript – 2022-06-28 – US$ 54.00 – Edited Transcript of ROIV.OQ earnings conference call or presentation 28-Jun-22 12:00pm GMT

Roivant Sciences Ltd at Goldman Sachs Global Healthcare Conference Transcript – 2022-06-14 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 14-Jun-22 3:40pm GMT

Roivant Sciences Ltd Tapinarof FDA Approval Investor Call Transcript – 2022-05-24 – US$ 54.00 – Edited Transcript of ROIV.OQ conference call or presentation 24-May-22 12:00pm GMT

Roivant Sciences Ltd at UBS Global Healthcare Conference Transcript – 2022-05-23 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 23-May-22 1:15pm GMT

Roivant Sciences Ltd Q3 2021 Earnings Call Transcript – 2022-02-14 – US$ 54.00 – Edited Transcript of ROIV.OQ earnings conference call or presentation 14-Feb-22 1:00pm GMT

Roivant Sciences Ltd at JPMorgan Healthcare Conference (Virtual) Transcript – 2022-01-10 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 10-Jan-22 7:15pm GMT

Roivant Sciences Ltd Q2 2021 Earnings Call Transcript – 2021-11-15 – US$ 54.00 – Edited Transcript of ROIV.OQ earnings conference call or presentation 15-Nov-21 1:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Roivant Sciences Ltd to Provide Update Regarding Initiation of Patent Litigation Against Moderna - Conference Call Transcript" Feb 28, 2022. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Roivant-Sciences-Ltd-to-Provide-Update-Regarding-Initiation-of-Patent-Litigation-Against-Moderna-Conference-Call-T15138254>
  
APA:
Thomson StreetEvents. (2022). Roivant Sciences Ltd to Provide Update Regarding Initiation of Patent Litigation Against Moderna - Conference Call Transcript Feb 28, 2022. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Roivant-Sciences-Ltd-to-Provide-Update-Regarding-Initiation-of-Patent-Litigation-Against-Moderna-Conference-Call-T15138254>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.